Neuroendocrine effects of thyroliberin and its analogs.
D000818:Animals; D001143:Arousal / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009842:Oligopeptides / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D051381:Rats; D012894:Sleep Stages / Q000187:drug effects*; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014793:Visual Cortex / Q000187:drug effects
D009842:Oligopeptides; C019070:pyroglutamyl-seryl-glycinamide; D013973:Thyrotropin-Releasing Hormone; C024667:pyroglutaminyl-seryl-leucinamide; D013972:Thyrotropin; D010424:Pentobarbital; D011761:Pyrrolidonecarboxylic Acid